Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management

Arch Dis Child. 2000 Aug;83(2):152-7. doi: 10.1136/adc.83.2.152.

Abstract

Background: Pulmonary interstitial fibrosis in children is a disease of unknown aetiology, usually associated with a poor prognosis.

Methods: In this case series we describe 11 children presenting over a 10 year period, managed conservatively and associated with a good prognosis.

Results: In six, symptoms were present from birth and 10 had symptoms at or before 3 months. Diagnosis was made using chest computed tomography and percutaneous lung biopsy. All patients were treated with oral prednisolone. In five no steroid response was noted. One patient responded to hydroxychloroquine. Home oxygen was required in five patients. At follow up all patients are alive at a median age of 6 years (range 1 to 12 years). The two recently diagnosed children have significant symptoms, seven have dyspnoea on exercise, and two are symptom free.

Conclusion: The good prognosis seen in these patients is different to previous case reports, indicating a greater than 50% mortality.

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Biopsy
  • Female
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Infant
  • Infant, Newborn
  • Lung / pathology
  • Male
  • Oxygen Inhalation Therapy / methods
  • Prednisolone / therapeutic use
  • Prognosis
  • Pulmonary Fibrosis / diagnosis
  • Pulmonary Fibrosis / pathology
  • Pulmonary Fibrosis / therapy*
  • Respiratory System Agents / therapeutic use
  • Retrospective Studies
  • Survivors
  • Tomography, X-Ray Computed

Substances

  • Anti-Inflammatory Agents
  • Respiratory System Agents
  • Hydroxychloroquine
  • Prednisolone